You are here
Home 🌿 Medical Cannabis News 🌿 New Study: Cannabis Patients See Improvement in Sleep, PTSD, and Pain Management 🌿New Study: Cannabis Patients See Improvement in Sleep, PTSD, and Pain Management
A promising new study involving patients in Canada—most of them over the age of 50—found they experienced improvements in the symptoms caused by chronic pain, post-traumatic stress disorder (PTSD), and sleep disorders after starting therapy with medical cannabis.
The study backs up past research that has shown cannabis has a positive impact, especially managing pain and improving sleep. It also provides scientific evidence why more seniors than ever are turning to medical marijuana to treat various ailments.
The study, conducted by Canadian and Italian researchers and published in the journal Frontiers of Public Health, found that more than 60 percent of patients reported improvements in their medical conditions after using cannabis.
"This real-world data shows that a large proportion of medical cannabis patients report moderate to substantial benefits from cannabis, both in terms of their overall condition and general wellbeing," the researchers wrote.
Chronic pain sufferers saw significant relief when treated with cannabis and CBD.
The study involved 214 patients in Canada who self-completed web-based surveys between January 2020 and August 2020. After an initial survey that recorded their medical information, each patient began a six-week trial period of cannabis treatment. In follow-up visits, they reported any changes and what, if any, cannabis products they felt caused those changes.
Patients ranged in age from 17-79, but most of the patients were more than 50 years old.
After six weeks, 76 percent of those who suffer from chronic pain reported improvement. Cannabis and CBD proved especially successful in treating two of the most common types of pain, nociceptive and neuropathic.
Patients also were evenly split about what type of treatment worked best. Among those who saw pain relief, 33 percent rated high CBD products as the most helpful, while 31 percent said the same of high THC products.
Cannabis improved the patients' sense of wellbeing
Those who suffer from PTSD, anxiety, and poor sleep at night also reported substantial improvements. The following lists four areas where people reported issues and the percentage who said they experienced improvements after six weeks of medical cannabis therapy.
- Sleep disorder (92.6 percent)
- Anxiety (84.8 percent)
- PTSD (81.3 percent)
- Arthritis (61.5 percent)
Patients also reported improvement in general wellbeing, with 89.8 percent reporting some level of improvement. Among those who experienced improvement, 42.1 percent reported feeling "better" or "a great deal better."
Researchers wrote that the study provides "the scientific evidence healthcare practitioners routinely state they require" and can also help lawmakers in "the drafting of future regulatory guidelines surrounding medical cannabis use."
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.